Results 1 to 10 of about 767,693 (290)

mRNA-Based Vaccines [PDF]

open access: yesVaccines, 2021
Increases in the world’s population and population density promote the spread of emerging pathogens. Vaccines are the most cost-effective means of preventing this spread.
Frank Kowalzik   +5 more
doaj   +4 more sources

Neo-Antigen mRNA Vaccines [PDF]

open access: yesVaccines, 2020
The interest in therapeutic cancer vaccines has caught enormous attention in recent years due to several breakthroughs in cancer research, among which the finding that successful checkpoint blockade treatments reinvigorate neo-antigen-specific T cells ...
Arthur Esprit   +5 more
doaj   +5 more sources

mRNA as a Therapeutics: Understanding mRNA Vaccines [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2022
Vaccination is one of the important approaches in the prevention and control of diseases. Although the capacity to present antigens other than the disease-specific antigen in the traditional vaccine composition provides a potential benefit by increasing ...
Ferdi Oğuz, Harika Atmaca
doaj   +3 more sources

Dangers of mRNA vaccines

open access: yesIndustrial Psychiatry Journal, 2021
“Necessity is the mother of invention:” An adage was brought to life with the emergence of the mRNA vaccine against the backdrop of the foreboding and mercurial COVID-19 pandemic.
Tahoora Ali   +4 more
doaj   +3 more sources

Progress and challenges of mRNA vaccines

open access: yesInterdisciplinary Medicine, 2023
Messenger RNA (mRNA) vaccines are third‐generation nucleic acid vaccines developed after first‐generation inactivated and live‐attenuated vaccines and second‐generation subunit and viral vector vaccines, characterized by a rapid response to pathogen ...
Liangru Lin   +3 more
doaj   +2 more sources

Research progress of mRNA vaccines for infectious diseases [PDF]

open access: yesEuropean Journal of Medical Research
mRNA vaccines for infectious diseases prevent diseases by stimulating the body to produce specific immune responses through mRNA molecules encoding pathogenic proteins.
Zhen Zhang   +5 more
doaj   +2 more sources

mRNA Vaccines: Current Applications and Future Directions [PDF]

open access: yesMedComm
Messenger RNA (mRNA) vaccines, as a novel class of biotherapeutics, leverage mRNA technology to instruct cells to produce specific antigens, thereby inducing an immune response.
Jianmei Li   +8 more
doaj   +2 more sources

From Design to Clinical Use: mRNA Vaccines for Infectious Diseases and Cancer [PDF]

open access: yesVaccines
mRNA vaccines represent a revolutionary advance in vaccinology, boasting advantages like rapid development, robust immunogenicity and flexible antigen design over traditional vaccines.
Yulin Cui, Ziyue Liang, Hua Cong
doaj   +2 more sources

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine Landscape

open access: yesFrontiers in Immunology, 2021
Recently, mRNA vaccines have become a significant type of therapeutic and have created new fields in the biopharmaceutical industry. mRNA vaccines are promising next-generation vaccines that have introduced a new age in vaccinology.
Chiranjib Chakraborty   +4 more
doaj   +1 more source

Nanotechnology-Enabled COVID-19 mRNA Vaccines

open access: yesEncyclopedia, 2021
COVID-19 mRNA vaccines contain synthetic mRNA sequences encoded for the Spike proteins expressed on the surface of SARS-CoV-2, and utilize the host cells to produce specific antigens that stimulate both humoral and cellular immunities.
Yu Gao   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy